Menrva Research Group, School of Mechatronics Systems Engineering and Engineering Science, Simon Fraser University, Vancouver, BC, Canada.
ETH Biomedical and Mobile Health Technology Lab, Zurich, Switzerland.
JMIR Mhealth Uhealth. 2024 Apr 11;12:e49751. doi: 10.2196/49751.
The opioid crisis continues to pose significant challenges to global public health, necessitating the development of novel interventions to support individuals in managing their substance use and preventing overdose-related deaths. Mobile health (mHealth), as a promising platform for addressing opioid use disorder, requires a comprehensive understanding of user perspectives to minimize barriers to care and optimize the benefits of mHealth interventions.
This study aims to synthesize qualitative insights into opioid users' acceptability and perceived efficacy of mHealth and wearable technologies for opioid use disorder.
A scoping review of PubMed (MEDLINE) and Google Scholar databases was conducted to identify research on opioid user perspectives concerning mHealth-assisted interventions, including wearable sensors, SMS text messaging, and app-based technology.
Overall, users demonstrate a high willingness to engage with mHealth interventions to prevent overdose-related deaths and manage opioid use. Users perceive mHealth as an opportunity to access care and desire the involvement of trusted health care professionals in these technologies. User comfort with wearing opioid sensors emerged as a significant factor. Personally tailored content, social support, and encouragement are preferred by users. Privacy concerns and limited access to technology pose barriers to care.
To maximize benefits and minimize risks for users, it is crucial to implement robust privacy measures, provide comprehensive user training, integrate behavior change techniques, offer professional and peer support, deliver tailored messages, incorporate behavior change theories, assess readiness for change, design stigma-reducing apps, use visual elements, and conduct user-focused research for effective opioid management in mHealth interventions. mHealth demonstrates considerable potential as a tool for addressing opioid use disorder and preventing overdose-related deaths, given the high acceptability and perceived benefits reported by users.
阿片类药物危机继续对全球公共卫生构成重大挑战,需要开发新的干预措施来支持个人管理药物使用和预防与过量相关的死亡。移动健康(mHealth)作为一种解决阿片类药物使用障碍的有前途的平台,需要全面了解用户观点,以最大限度地减少护理障碍并优化 mHealth 干预措施的益处。
本研究旨在综合定性研究,了解阿片类药物使用者对 mHealth 和可穿戴技术治疗阿片类药物使用障碍的可接受性和感知效果。
对 PubMed(MEDLINE)和 Google Scholar 数据库进行了范围综述,以确定有关 mHealth 辅助干预措施的阿片类药物使用者观点的研究,包括可穿戴传感器、短信文本消息和基于应用程序的技术。
总体而言,用户非常愿意使用 mHealth 干预措施来预防与过量相关的死亡和管理阿片类药物使用。用户认为 mHealth 是获得护理的机会,并希望在这些技术中得到信任的医疗保健专业人员的参与。用户对佩戴阿片类药物传感器的舒适度是一个重要因素。个性化内容、社会支持和鼓励是用户所期望的。隐私问题和有限的技术获取是护理障碍。
为了最大限度地为用户带来益处并最小化风险,实施强大的隐私措施、提供全面的用户培训、整合行为改变技术、提供专业和同伴支持、提供量身定制的信息、纳入行为改变理论、评估改变的准备情况、设计减少污名化的应用程序、使用视觉元素以及进行以用户为中心的研究对于 mHealth 干预措施中有效的阿片类药物管理至关重要。鉴于用户报告的可接受性和感知益处,mHealth 具有相当大的潜力,可以作为治疗阿片类药物使用障碍和预防与过量相关的死亡的工具。